Search Results 251-260 of 18516 for total bilirubin

1. Testing Olaparib For One Or Two Years, With Or Without Bevacizumab, To Treat Ovarian Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (patients with known Gilbert's disease who have bilirubin level ≤ 3 x institutional ULN ...

2. A Study of Lutetium Lu 177 Dotatate (Lutathera®) in Patients with Inoperable, Progressive Meningioma after External Beam Radiation Therapy - Mayo Clinic

   ... total bilirubin =\< 3.0 x ULN with direct bilirubin =\< 1.5 x ULN in patients with well-documented Gilbert's syndrome) (obtained =\< 14 days prior to ...

3. Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer - Mayo Clinic

   Total bilirubin < 2 x institutional upper limit of normal (ULN); AST or ALT < 3 x institutional ULN. Negative pregnancy test done ≤7 days prior to ...

4. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers - Mayo Clinic

   Phase II part 2: For patients with hepatic metastases - no more than 3 hepatic lesions in total ... Total bilirubin ≤ 1.5 x ULN;; Serum transaminases (alanine ...

5. Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer - Mayo Clinic

   ... total bilirubin ≤ 2.0 times ULN and direct bilirubin within normal limits are permitted. Aspartate aminotransferase (AST) (serum glutamic oxaloacetic ...

6. Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

   ... serum creatinine based on age/gender as follows. 0.4 mg/dL (1 to 5 ... Total bilirubin ≤ 1.5 times upper limit of normal (ULN) for age; AST or ALT ...

7. Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma - Mayo Clinic

   ... serum creatinine of ≤ 1.5 mg/dl. Patients must have adequate liver function as defined by total bilirubin of ≤ 1.5 mg/dl and ALT or AST < 2.5 times the ...

8. A Study of Tamoxifen Citrate for Treating Patients with Metastatic or Recurrent Breast Cancer - Mayo Clinic

   Total bilirubin ≤ 1.5 times upper limit of normal (ULN); ALT and AST ≤ 2.5 times ULN (≤ 5 times ULN if liver metastases present); Not pregnant or nursing ...

9. Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma - Mayo Clinic

   Total bilirubin =< 1.5 x upper limit of normal (ULN) for age; Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) or serum ...

10. Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors

    * Total bilirubin ≤1.5 x ULN and \<3 mg/dL for patients with Gilbert's disease * Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤3 x ULN